
National HealthCare Corporation NHC
$ 170.21
-1.52%
Annual report 2025
added 02-26-2026
National HealthCare Corporation Cost of Revenue 2011-2026 | NHC
Cost of Revenue is a financial metric that reflects all direct costs associated with the production of goods or the provision of services that directly led to revenue during the reporting period. It is the total amount of expenses incurred by the company to deliver its products or services, including both production costs and related expenses necessary for delivery or customer support.What is included in the cost of revenue
| Cost Category | Examples |
|---|---|
| Production Costs | Materials, wages of production staff, depreciation of equipment |
| Service and Support | Customer service, user support, technical assistance |
| Delivery and Logistics | Packaging, delivery of goods to customers |
| Hosting and Infrastructure | Servers, cloud platforms (especially for IT and SaaS companies) |
| Content and Licenses | License purchases, production royalties (e.g., in streaming services) |
Importance of the Metric
- Helps to understand how costly the revenue-generating process is.
- A high cost of revenue may indicate:
Poor cost control
Low operational efficiency - A low cost of revenue combined with high revenue indicates high profitability and business competitiveness.
Annual Cost of Revenue National HealthCare Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 921 M | 811 M | 712 M | 686 M | 666 M | 621 M | 593 M | 583 M | 572 M | 548 M | 533 M | 510 M | 454 M | 427 M | 429 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 921 M | 427 M | 604 M |
Quarterly Cost of Revenue National HealthCare Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 233 M | 227 M | 228 M | - | 213 M | 180 M | 183 M | - | 183 M | 175 M | 168 M | - | 173 M | 175 M | 171 M | - | 170 M | 157 M | 149 M | - | 152 M | 157 M | 147 M | - | 152 M | 148 M | 141 M | - | 149 M | 145 M | 140 M | - | 146 M | 143 M | 138 M | - | 140 M | 135 M | 130 M | - | 135 M | 132 M | 126 M | - | 129 M | 126 M | 120 M | - | 114 M | 109 M | 107 M | - | 107 M | 105 M | 106 M | - | 107 M | 105 M | 109 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 233 M | 105 M | 149 M |
Cost of Revenue of other stocks in the Care facilities industry
| Issuer | Cost of Revenue | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Amedisys
AMED
|
1.33 B | - | 0.01 % | $ 3.3 B | ||
|
Apollo Medical Holdings
AMEH
|
1.17 B | - | -2.11 % | $ 1.84 B | ||
|
Concord Medical Services Holdings Limited
CCM
|
463 M | $ 3.78 | -1.54 % | $ 495 M | ||
|
Addus HomeCare Corporation
ADUS
|
961 M | $ 103.75 | -1.83 % | $ 1.87 B | ||
|
Fresenius Medical Care AG & Co. KGaA
FMS
|
12.5 B | $ 22.98 | -0.24 % | $ 7.05 B | ||
|
Chemed Corporation
CHE
|
1.58 B | $ 409.6 | -0.34 % | $ 6.15 B | ||
|
Avalon GloboCare Corp.
AVCO
|
1.43 M | - | 26.45 % | $ 70.6 M | ||
|
The Ensign Group
ENSG
|
4.02 B | $ 206.45 | -2.64 % | $ 11.8 B | ||
|
Aesthetic Medical International Holdings Group Limited
AIH
|
376 M | - | 10.96 % | $ 46.2 M | ||
|
HCA Healthcare
HCA
|
32.9 B | $ 531.14 | -2.44 % | $ 126 B | ||
|
Hanger
HNGR
|
398 M | - | - | $ 732 M | ||
|
Encompass Health Corporation
EHC
|
3.12 B | $ 107.56 | -1.28 % | $ 10.8 B | ||
|
Acadia Healthcare Company
ACHC
|
1.69 B | $ 24.48 | 1.74 % | $ 2.24 B | ||
|
Phibro Animal Health Corporation
PAHC
|
896 M | $ 51.46 | -0.83 % | $ 2.08 B | ||
|
AMN Healthcare Services
AMN
|
2.54 B | $ 21.81 | 0.14 % | $ 854 M | ||
|
LHC Group
LHCG
|
1.4 B | - | - | $ 5.27 B | ||
|
American Shared Hospital Services
AMS
|
19.2 M | $ 2.08 | -0.17 % | $ 13.5 M | ||
|
Healthcare Services Group
HCSG
|
1.6 B | $ 20.94 | -1.74 % | $ 1.52 B | ||
|
The Joint Corp.
JYNT
|
9.17 M | $ 8.69 | -2.36 % | $ 126 M | ||
|
ModivCare
MODV
|
2.37 B | - | -25.23 % | $ 6.12 M | ||
|
IMAC Holdings
IMAC
|
305 K | - | -1.77 % | $ 25.4 M | ||
|
Sanara MedTech
SMTI
|
7.85 M | $ 19.43 | -3.29 % | $ 161 M | ||
|
Tenet Healthcare Corporation
THC
|
8.7 B | $ 239.35 | -2.18 % | $ 21.6 B | ||
|
Community Health Systems
CYH
|
1.86 B | $ 3.36 | -2.19 % | $ 449 M | ||
|
Elanco Animal Health Incorporated
ELAN
|
2.12 B | $ 23.82 | -2.54 % | $ 11.8 B | ||
|
Novo Integrated Sciences
NVOS
|
7.55 M | - | -13.87 % | $ 1.52 M | ||
|
U.S. Physical Therapy
USPH
|
462 M | $ 82.42 | -1.99 % | $ 1.25 B | ||
|
Oak Street Health
OSH
|
438 M | - | 0.03 % | $ 9.53 B | ||
|
The Pennant Group
PNTG
|
769 M | $ 32.99 | -1.64 % | $ 1.14 B | ||
|
Select Medical Holdings Corporation
SEM
|
4.82 B | $ 16.25 | -0.03 % | $ 1.99 B | ||
|
MEDNAX
MD
|
1.54 B | $ 19.29 | -2.97 % | $ 1.62 B | ||
|
Option Care Health
OPCH
|
4.56 B | $ 30.63 | -0.31 % | $ 4.97 B | ||
|
Ontrak
OTRK
|
4.02 M | - | -11.98 % | $ 1.53 M | ||
|
Surgery Partners
SGRY
|
971 M | $ 13.89 | -1.35 % | $ 1.77 B | ||
|
SunLink Health Systems
SSY
|
18.3 M | - | 17.98 % | $ 7.81 M | ||
|
Universal Health Services
UHS
|
8.08 B | $ 195.05 | -3.56 % | $ 12.4 B | ||
|
Tivity Health
TVTY
|
278 M | - | 0.09 % | $ 1.6 B |